| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/29/2006 | US20060142594 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/29/2006 | US20060142376 Preparing levetiracetam by deaminomethylation of the pure enantiomer intermediate: N-(dialkylamino- (or -pyrrolidinyl-, piperidinyl-, morpholinyl-, piperazinyl- or alkylpiperazinyl-)methyl)2-pyrrolidonylbutyramide or its acid addition salt |
| 06/29/2006 | US20060142369 Delta 1-pyrrolines used as pesticides |
| 06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 06/29/2006 | US20060142277 Substituted aralkyl derivatives |
| 06/29/2006 | US20060142204 Pyrrolidine derivatives for use in treating heaptitis c virus infection |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | CA2591937A1 Tetralin and indane derivatives and uses thereof |
| 06/29/2006 | CA2591603A1 Process for preparing pyrrole derivatives and intermediates |
| 06/29/2006 | CA2590985A1 Cycloalkylamine derivatives |
| 06/29/2006 | CA2590246A1 Novel ligands that modulate rar receptors, and use thereof in human medicine and in cosmetics |
| 06/29/2006 | CA2589629A1 Quinoline tachykinin receptor antagonists |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/28/2006 | EP1674452A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 06/28/2006 | EP1674096A2 Hypoglycemics comprising organic zinc (II) complexes |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673082A2 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
| 06/28/2006 | EP1673078A2 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1492539B1 Statin therapy for enhancing cognitive maintenance |
| 06/28/2006 | EP1341758B1 Coniosetin and derivatives thereof, method for producing the same and use thereof |
| 06/28/2006 | EP1301829A4 Radiation sensitive compositions containing image quality and profile enhancement additives |
| 06/28/2006 | EP0693129B1 Method of inhibiting the transcription of genes |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1795173A Captopril derivatives |
| 06/28/2006 | CN1794987A Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067549 Pyrrolidone carboxamides |
| 06/27/2006 | US7067542 Diaminediols for the treatment of Alzheimer's disease |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067509 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | WO2006064944A1 Substituted pyrrole derivative |
| 06/22/2006 | WO2006064351A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006064336A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006064332A1 N-pyrrolidin-3yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006063763A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/22/2006 | WO2006063727A1 Method for cleaning deposits from equipment that have accumulated during a method for recovering nmp, by the introduction of hot water and agitation |
| 06/22/2006 | WO2006063706A1 Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives |
| 06/22/2006 | WO2006013049A3 Benzyloxy derivatives as maob inhibitors |
| 06/22/2006 | WO2006011041A3 Crystalline forms of (r-(r*))-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-hept anoic acid calcium salt (2:1) |
| 06/22/2006 | WO2005094897A3 Pegylated ion channel modulating compounds |
| 06/22/2006 | WO2005044795A8 Process for the preparation of ccr-2 antagonist |
| 06/22/2006 | US20060135790 Process for the preparation of an alpha-amino carbonyl compound |
| 06/22/2006 | US20060135783 Multifunctional amine capture agents |
| 06/22/2006 | US20060135773 Trisubstituted nitrogen modulators of tyrosine phosphatases |
| 06/22/2006 | US20060135714 Conjugation reactions |
| 06/22/2006 | US20060135597 Administering a bithiophene substituted by a carboxyalkyl group and a pyridinyl or pyrimidinyl group to treat irritable bowel syndrome, chronic heart failure, angina, cardiac infarction, cerebral infarction, pollakiuria, urinary incontinence, or, cerebral ischemia |
| 06/22/2006 | US20060135594 Dihydropyrrole derivatives; 3-{(2S)-4-(2,5-difluorophenyl)-1-[(dimethylamino)carbonyl]-2,5-dihydro- 1H-pyrrol-2-yl}phenyl dihydrogen phosphate; anticarcinogenic agents; cellular proliferative diseases; specificity; side effect reduction |
| 06/22/2006 | US20060135593 N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/22/2006 | US20060135536 Ion channel modulating activity I |
| 06/22/2006 | US20060135505 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/22/2006 | US20060134711 For determination of drugs of abuse in biological samples, in particular, to immunoassay, for determination of amphetamine-class drugs, and more particularly, to methamphetamine derivatives |
| 06/22/2006 | US20060134465 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 06/22/2006 | CA2591415A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | CA2590229A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | CA2590226A1 N-pyrrolidin-3yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | CA2589042A1 Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives |
| 06/22/2006 | CA2587934A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP1671947A1 Process for preparing pyrrole derivatives and intermediates |
| 06/21/2006 | EP1670787A2 Cytokine inhibitors |
| 06/21/2006 | EP1670757A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 06/21/2006 | EP1670756A1 Heterocyclyl compounds |
| 06/21/2006 | EP1670755A2 Pyrovalerone analogs and therapeutic uses thereof |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1670476A2 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791592A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791574A Process for rectifying N-vinyl-2-pyrrolidone |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791568A Hsp90 family protein inhibitors |
| 06/21/2006 | CN1791401A Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
| 06/21/2006 | CN1791395A 免疫抑制剂化合物及组合物 Immunosuppressant compounds and compositions |
| 06/21/2006 | CN1789247A Method for preparing chiral disubstituted or alpha, alpha'-double instituted N-acylpyrrolidine or N-acylpiperidine |
| 06/21/2006 | CN1789245A Sulfur-containing, polymerizable benzophenone photoinitiator and preparation method thereof |
| 06/21/2006 | CN1789244A Pyrrolidine derivative, preparation method thereof and pharmaceutical composition containing the compound |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260218C PDF enzyme inhibitor-hydroxamic acid serial compounds, synthetic method and use thereof |
| 06/21/2006 | CN1260213C Preparation of non-crystalline at orvastatin calcium |
| 06/21/2006 | CN1260212C Method of purifying N-(2-hydroxy ethyl)-2-pyrrolidone |
| 06/20/2006 | US7064218 Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7064199 Process for the manufacture of 3-amino-pyrrolidine derivatives |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7063928 An apparatus having an organophotoreceptor in the form of a flexible belt threaded around support rollers and having a charge transfer compound comprising a fluorenone hydrazone including other functional groups and phenyl and heteraryl rings;used with liquid toner; durability |
| 06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061585A1 Pyrrolidine compounds |
| 06/15/2006 | WO2006061366A1 Pyrrolidin-2-one derivatives for use as dp1 receptor agonists |
| 06/15/2006 | WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | WO2006044425A3 Ophthalmic compositions for treating ocular hypertension |
| 06/15/2006 | WO2006039383A3 Synthesis by chiral diamine-mediated asymmetric alkylation |